摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺 | 63932-26-3

中文名称
6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺
中文别名
——
英文名称
C-(6,7-dihydro-4H-thieno[3,2-c]pyran-4-yl)-methylamine
英文别名
(6,7-dihydro-4H-thieno[3,2-c]pyran-4-yl)methanamine;4-Aminomethyl-6,7-dihydro-4H-thieno<3,2-c>pyran;4H,6H,7H-thieno[3,2-c]pyran-4-ylmethanamine;6,7-dihydro-4H-thieno[3,2-c]pyran-4-ylmethanamine
6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺化学式
CAS
63932-26-3
化学式
C8H11NOS
mdl
MFCD08690319
分子量
169.247
InChiKey
NMVKUIFBCHQTHO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    301.0±32.0 °C(Predicted)
  • 密度:
    1.195±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    63.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090

SDS

SDS:ded932b1ccdae02556f5379c6c991059
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Multicyclic compounds and methods of use thereof
    申请人:Shao Liming
    公开号:US08710245B2
    公开(公告)日:2014-04-29
    Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.
    本文提供多环化合物、其合成方法、包含该化合物的药物组合物以及使用该化合物的方法。所提供的化合物对于治疗、预防和/或管理各种神经系统疾病,包括但不限于精神病和精神分裂症具有用途。
  • MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
    申请人:Shao Liming
    公开号:US20130109677A1
    公开(公告)日:2013-05-02
    Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.
    本文提供了多环化合物,其合成方法,包括该化合物的药物组合物,以及使用方法。本文提供的化合物对于治疗、预防和/或管理各种神经系统疾病非常有用,包括但不限于精神病和精神分裂症。
  • Methods of treating schizophrenia
    申请人:Sunovion Pharmaceuticals Inc.
    公开号:US11129807B2
    公开(公告)日:2021-09-28
    Provided herein are methods for determining if a compound has potential efficacy for the treatment for a specific symptom domain of schizophrenia, such as for example, the treatment of a negative symptom of schizophrenia. In addition, provided herein are methods of determining the prominent symptom domain of a subject suffering from schizophrenia. Further, provided herein are various methods for the treatment of the negative symptoms, cognitive dysfunction symptoms, or both, associated with schizophrenia comprising administering to a subject a therapeutically or prophylactically effective amount of various compounds.
    本文提供的方法用于确定化合物是否对治疗精神分裂症的特定症状域具有潜在疗效,例如治疗精神分裂症的阴性症状。此外,本文还提供了确定精神分裂症患者突出症状域的方法。此外,本文还提供了治疗与精神分裂症相关的阴性症状、认知功能障碍症状或两者的各种方法,包括向受试者施用治疗或预防有效量的各种化合物。
  • US20140256712A1
    申请人:——
    公开号:——
    公开(公告)日:——
  • METHODS OF TREATING SCHIZOPHRENIA
    申请人:Sunovion Pharmaceuticals Inc.
    公开号:US20200129477A1
    公开(公告)日:2020-04-30
    Provided herein are methods for determining if a compound has potential efficacy for the treatment for a specific symptom domain of schizophrenia, such as for example, the treatment of a negative symptom of schizophrenia. In addition, provided herein are methods of determining the prominent symptom domain of a subject suffering from schizophrenia. Further, provided herein are various methods for the treatment of the negative symptoms, cognitive dysfunction symptoms, or both, associated with schizophrenia comprising administering to a subject a therapeutically or prophylactically effective amount of various compounds.
查看更多

同类化合物

化合物SEP-363856HYDROCHLORIDE 6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸乙酯 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸 5,7-二氢-4H-噻吩并[2,3-c]吡喃-3-羧酸 5,7-二氢-4H-噻吩并[2,3-C]吡喃-3-羧酸乙酯 4-(2-羟基乙基)-4-甲基-6,7-二氢-4h-噻吩并[3,2-c]吡喃 4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 4',5'-二氢-螺[哌啶-4,7'-[7H]噻吩并[2,3-c]吡喃]-1-羧酸叔丁酯 2-氯-4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 2-氨基-5,5-二甲基-4,7-二氢-5H-噻吩并[2,3-C]吡喃-3-羧酸叔丁酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-羧酸乙酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-甲腈 2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 (4-甲基-6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-基)乙酸 (2-羧基噻吩-3-基)乙酸酐 2-((8-fluoro-5-methylchroman-6-yl)methyl)-N-methylbenzamide 2,4-(2,5,8,11-tetraoxa)dodecano-3-bromo-5-phenylthiophene 2-(cycloheptanecarbonyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid 2-(Cyclopentanecarbonyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid ethyl ester 2-[(hexahydro-2,5-methanopentalen-3a(1H)-ylcarbonyl)amino]-N-[(3R)-tetrahydrofuran-3-yl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide N-[5-(4-cyanophenyl)methyl-2-thiazolyl]-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxamide 6,7-dihydro-N-methyl-4H-Thieno[3,2-c]pyran-4-methanamine hydrochloride 5-Methyl-7-oxo-4,5-dihydro-7H-thieno<2.3-c>pyran 5,7-dihydro-7-(4-nitrophenyl)-4H-thieno[2,3-c]pyran 1,9-Dimethyl-4,6-dihydrodithieno<3,4-c:3',4'-e>oxepin-4-on N-(3-cyano-5,7-dihydro-4H-thieno[2,3-c]pyran-2-ylcarbamoyl)benzamide {4-methyl-4,6-dihydrothieno[2,3-c]furan-2-yl}hexahydro-2,5-methanopentalene-3a(1H)-carboxylic acid N-benzoyl-N'-(3-cyano-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)thiourea 5,7-dihydro-7,7-dimethyl-4H-thieno[2,3-c]pyran 5,7-dihydro-7-pentyl-4H-thieno[2,3-c]pyran 3-(benzo[d]thiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-amine (2-ethyl-6,7-dihydro-4H-thieno[3,2-c]pyran-4-yl)methanamine hydrochloride 2-Bromo-5,5-dimethyl-5H-thieno<3,2-b>pyran